TrialBMC cancer2026

Effectiveness and cost-effectiveness of ozone treatment in patients with paraesthesia (numbness, tingling) secondary to chemotherapy-induced peripheral neuropathy: randomized, triple-blind clinical trial (OzoParQT).

Bernardino Clavo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.